BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8434456)

  • 1. Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
    Minocha A; Dean HA; Pittsley RA
    Vet Hum Toxicol; 1993 Feb; 35(1):45-8. PubMed ID: 8434456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute, reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis.
    Clegg DO; Furst DE; Tolman KG; Pogue R
    J Rheumatol; 1989 Aug; 16(8):1123-6. PubMed ID: 2585411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.
    Kent PD; Luthra HS; Michet C
    J Rheumatol; 2004 Sep; 31(9):1727-31. PubMed ID: 15338491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.
    Rau R; Karger T; Herborn G; Frenzel H
    J Rheumatol; 1989 Apr; 16(4):489-93. PubMed ID: 2473207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.
    Ideguchi H; Ohno S; Ishigatsubo Y
    J Clin Rheumatol; 2007 Apr; 13(2):73-8. PubMed ID: 17414533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis.
    Keim D; Ragsdale C; Heidelberger K; Sullivan D
    J Rheumatol; 1990 Jun; 17(6):846-8. PubMed ID: 2388211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
    Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
    J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate: the emerging drug of choice for serious rheumatoid arthritis.
    Salach RH; Cash JM
    Clin Ther; 1994; 16(6):912-22; discussion 911. PubMed ID: 7697687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A; Poulsen H
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood cell concentration of methotrexate in long-term therapy of inflammatory rheumatic diseases].
    Leeb B; Dunky A; Ogris E; Wohanka A; Schenk G; Fischer M; Tausch G; Eberl R
    Acta Med Austriaca; 1988; 15(5):140-4. PubMed ID: 3146207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rheumatoid arthritis, methothrexate, and pulmonary fibrosis: which evidences?].
    Schaller D; Nendaz M; Gabay C
    Rev Med Suisse; 2010 Mar; 6(240):547-8, 550, 552-4. PubMed ID: 20408459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate.
    Biasi D; Bambara LM; Carletto A; Casaril M; Capra F; Caramaschi P; Corrocher R
    J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
    Bjorkman DJ; Boschert M; Tolman KG; Clegg DO; Ward JR
    Arthritis Rheum; 1993 Dec; 36(12):1697-701. PubMed ID: 8250989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
    Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
    Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate.
    Usman AR; Yunus MB
    J Rheumatol; 1996 Jun; 23(6):1095-7. PubMed ID: 8782146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.